Seroprevalence of autoantibodies against brain antigens in health and disease

Annals of Neurology

Volumn 76, Issue 1, 2014, Pages 82-94

  Dahm, Liane ^a   Ott, Christoph ^a   Steiner, Johann ^b,c   Stepniak, Beata ^a   Teegen, Bianca ^d   Saschenbrecker, Sandra ^d   Hammer, Christian ^a   Borowski, Kathrin ^d   Begemann, Martin ^a   Lemke, Sandra ^d   Rentzsch, Kristin ^d   Probst, Christian ^d   Martens, Henrik ^e   Wienands, Jürgen ^f   Spalletta, Gianfranco ^g   Weissenborn, Karin ^h   Stöcker, Winfried ^d   Ehrenreich, Hannelore ^a,i  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c Center for Behavioral Brain Sciences   (Germany)

^d Institute for Experimental Immunology   (Germany)

^e SYNAPTIC SYSTEMS GMBH   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ Deutsche Forschungsgemeinschaft   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPAR 1 ANTIBODY; AMPAR 2 ANTIBODY; AMPHIPHYSIN; AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; BRAIN ANTIGEN; CONTACTIN ASSOCIATED PROTEIN 2; CV2 ANTIBODY; DNER SNTIBODY; GABAR B1 ANTIBODY; GABAR B2 ANTIBODY; GLRA1B ANTIBODY; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GRM5 ANTIBODY; HU PROTEIN; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; LGL1 ANTIBODY; MA1 ANTIGEN; MA2 ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; N METHYL D ASPARTATE RECEPTOR SUBUNIT NR1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1AB; RECOVERIN; RHO GTPASE ACTIVATING PROTEIN 26; RI ANTIBODY; TR ANTIBODY; UNCLASSIFIED DRUG; ZIC4 ANTIBODY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGEN EXPRESSION; ARTICLE; BORDERLINE STATE; BRAIN DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HEK293 CELL LINE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PARKINSON DISEASE; PERSONALITY DISORDER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCHIZOPHRENIA; SEROPREVALENCE;

ADULT; AGED; ANIMALS; AUTOANTIBODIES; FEMALE; GERMANY; HAPLORHINI; HEK293 CELLS; HUMANS; MALE; MASS SCREENING; MENTAL DISORDERS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; REFERENCE VALUES; SEROEPIDEMIOLOGIC STUDIES;

EID: 84904791725     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24189     Document Type: Article

References (31)

1. Diamond B, Huerta PT, Mina-Osorio P, et al. Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol 2009; 9: 449-456.
2. Sutton I, Winer JB,. The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci (Lond) 2002; 102: 475-486.
3. Levin EC, Acharya NK, Han M, et al. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown. Brain Res 2010; 1345: 221-232.
4. Cohen IR, Young DB,. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 1991; 12: 105-110.
5. Poletaev A, Osipenko L,. General network of natural autoantibodies as immunological homunculus (immunculus). Autoimmun Rev 2003; 2: 264-271.
6. Nagele EP, Han M, Acharya NK, et al. Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease. PLoS One 2013; 8: e60726.
7. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-1098.
8. Zandi MS, Irani SR, Lang B, et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011; 258: 686-688.
9. Pollak TA, McCormack R, Peakman M, et al. Prevalence of anti-N-methyl-d-aspartate (NMDA) antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychol Med 2013;Dec 13: 1-13. [Epub ahead of print].
10. Hammer C, Stepniak B, Schneider A, et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry (in press) advance online publication, 3 June 2014; doi:10.1038/mp.2014.52.
11. Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry 2013; 70: 271-278.
12. Steiner J, Teegen B, Schiltz K, et al. Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy controls revisited. JAMA Psychiatry (in press). Accessed on May 28, 2014
13. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36.
14. De Camilli P, Thomas A, Cofiell R, et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J Exp Med 1993; 178: 2219-2223.
15. Jarius S, Wandinger KP, Horn S, et al. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization. J Neuroinflammation 2010; 7: 21.
16. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133: 2734-2748.
17. Xiao BG, Linington C, Link H,. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 1991; 31: 91-96.
18. Kaufman DL, Erlander MG, Clare-Salzler M, et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-292.
19. Voltz R, Gultekin SH, Rosenfeld MR, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999; 340: 1788-1795.
20. Peterson K, Rosenblum MK, Kotanides H, Posner JB,. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992; 42: 1931-1937.
21. Dalmau J, Gultekin SH, Voltz R, et al. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 1999; 122 (pt 1): 27-39.
22. Probst C, Saschenbrecker S, Stoecker W, Komorowski L,. Anti-neuronal autoantibodies: current diagnostic challenges. Mult Scler Relat Disord 2014; 3: 303-320.
23. Ribbe K, Friedrichs H, Begemann M, et al. The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry 2010; 10: 91.
24. Begemann M, Grube S, Papiol S, et al. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry 2010; 67: 879-888.
25. Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J,. Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011; 231: 86-91.
26. Zhang J, Jacobi AM, Wang T, et al. Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun 2009; 33: 270-274.
27. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014; 13: 167-177.
28. Reiber H, Peter JB,. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2001; 184: 101-122.
29. Zlokovic BV,. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57: 178-201.
30. Brimberg L, Sadiq A, Gregersen PK, Diamond B,. Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol Psychiatry 2013; 18: 1171-1177.
31. During MJ, Symes CW, Lawlor PA, et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000; 287: 1453-1460.